IP Verse

Hanmi Pharm competitive analysis

Loading summary...

Latest patents of Hanmi Pharm opposed by its competitors

Explore Hanmi Pharm's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3421034
Nov 16, 2022Composite Capsule Preparation Containing Tadalafil And Tamsulosin And Having Improved Stability And Elution Rate1
EP2877201
Jun 5, 2019A Liquid Formulation Of Long-Acting Insulin And Insulinotropic Peptide1

Latest publications and patents of Hanmi Pharm New

Explore the latest publications and patents granted to Hanmi Pharm, showcasing their recent innovations and technological advancements.

Last updated on: Oct 19, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Hanmi Pharm

EP3421034
Nov 16, 2022Composite Capsule Preparation Containing Tadalafil And Tamsulosin And Having Improved Stability And Elution RateRevoked
EP2877201
Jun 5, 2019A Liquid Formulation Of Long-Acting Insulin And Insulinotropic PeptideGranted And Under Opposition

Latest PTAB cases involving Hanmi Pharm

Discover the latest PTAB cases involving Hanmi Pharm, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Hanmi Pharm with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
HANMI PHARM - 2 - -
GENERICS UK214 - - -
JAMES POOLE153 - - -